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Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelABSTRACT Protegrin-1 (PG-1) is an 18 residues long, cysteine-rich b-sheet antimicrobial peptide (AMP). PG-1 induces strong
cytotoxic activities on cell membrane and acts as a potent antibiotic agent. Earlier we reported that its cytotoxicity is mediated by
its channel-forming ability. In this study, we have examined the amyloidogenic fibril formation properties of PG-1 in comparison
with a well-defined amyloid, the amyloid-b (Ab1–42) peptide. We have used atomic force microscopy (AFM) and thioflavin-T
staining to investigate the kinetics of PG-1 fibrils growth and molecular dynamics simulations to elucidate the underlying mech-
anism. AFM images of PG-1 on a highly hydrophilic surface (mica) show fibrils with morphological similarities to Ab1–42 fibrils.
Real-time AFM imaging of fibril growth suggests that PG-1 fibril growth follows a relatively fast kinetics compared to the Ab1–42
fibrils. The AFM results are in close agreement with results from thioflavin-T staining data. Furthermore, the results indicate that
PG-1 forms fibrils in solution. Significantly, in contrast, we do not detect fibrillar structures of PG-1 on an anionic lipid bilayer
2-dioleoyl-sn-glycero-3-phospho-L-serine/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; only small PG-1 oligomers
can be observed. Molecular dynamics simulations are able to identify the presence of these small oligomers on the membrane
bilayer. Thus, our current results show that cytotoxic AMP PG-1 is amyloidogenic and capable of forming fibrils. Overall,
comparing b-rich AMPs and amyloids such as Ab, in addition to cytotoxicity and amyloidogenicity, they share a common struc-
tural motif, and are channel forming. These combined properties support a functional relationship between amyloidogenic
peptides and b-sheet-rich cytolytic AMPs, suggesting that amyloids channels may have an antimicrobial function.INTRODUCTIONAntimicrobial peptides (AMPs) are small peptides with
a strong antibiotic activity against a wide range of microor-
ganisms, including enveloped viruses, fungi, and bacteria.
They usually exert their effect by killing the invading
bacteria directly (bactericidal), rather than by inhibiting
their proliferation as bacteriostatic antibiotics (1–3). Their
ability to selectively target bacterial cells stems from the
difference in the membrane composition of bacterial and
mammalian cells, such as lipopolysaccharides (LPS, also
known as endotoxin) and peptidoglycans, and differing
transmembrane potentials (4,5). AMPs form five different
subgroups based on their amino acid composition and struc-
ture (1,2,6–9). In the cationic subgroup of disulfide-bonded,
b-sheet forming peptides,which includes protegrin-1 (PG-1),
the presence of positively charged amino acid residues
allows their strong interaction with the negatively charged
lipid headgroups present in the outer leaflets of bacterial
cell membranes. Upon this initial contact with a bacterialSubmitted November 10, 2010, and accepted for publication January 21,
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0006-3495/11/04/1775/9 $2.00cell, cytotoxicity primarily takes place by disrupting the
bacterial membrane via pore formation (1,8,10–16). Other
cysteine-rich cationic AMP known as defensin also forms
pores, similar to those formed by PG-1 (17). The AMPs
positive charge disfavors their interaction with the electri-
cally neutral outer leaflet of mammalian cells, because
negatively charged headgroups are primarily located in the
inner leaflet of the mammalian cell membrane (4,5,8).
Significantly, a number of AMPs of the cationic a-helix
forming family have been reported to form fibrillar aggre-
gates with amyloid-like properties in the presence of lipid
bilayers (18–22).
PG-1 is an 18 residues (RGGRLCYCRRRFCVCVGR)
cysteine-rich b-hairpin AMP with ~2 kDa molecular mass
(6,23). Four cysteine residues, producing disulfide S–S
bonds at the 6Cys-15Cys and 8Cys-13Cys locations, provide
PG-1 the ability to form b-sheets (1,13,23,24). The peptide
has six arginine residues that allow PG-1 to interact via
strong electrostatic interactions with surfaces of lipid
bilayers composed of negatively charged headgroups.
The hydropathy index of PG-1 is 0.25, which is relatively
close to the value of 0.2 for the Alzheimer’s b-amyloids
(Ab), Ab1–42 peptide (25,26).
PG-1’s structural analogy with Ab, in particular with
respect to b-sheet formation, makes PG-1 a good candidate
to possess some of the properties observed for amyloids
(13,24). Ab fibrils have been the subject of intense studiesdoi: 10.1016/j.bpj.2011.01.072
1776 Jang et al.(27–30). The Ab morphology is highly polymorphic with
a rugged oligomeric and fibril energy landscape (31), and
they form heterogeneous ion channels with a central pore
(32–43). Recently, it has been found that the Ab1–42 and
Ab1–40 peptides exert antimicrobial activity comparable to
that of the a-helical LL-37 AMP (44). We and others have
shown that the b-forming PG-1 peptide exhibits amyloid-
like ion channel behavior in model lipid bilayers
(10,13,24). These channels are likely to precede the final
disruption of lipid bilayers via massive pore formations
(11,15,16). The structural similarities between AMPs and
Ab peptides provide a starting point to understand common
patterns in the behavior of these systems.
In this study, we present evidence for the amyloidogenic
property of the PG-1 peptide. We employed atomic force
microscopy (AFM) to investigate the conformational adapt-
ability of PG-1 peptides in different environments, e.g., on
the surfaces of the highly hydrophilic mica and an anionic
lipid bilayer composed of 2-dioleoyl-sn-glycero-3-phos-
pho-L-serine (DOPS) and 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE). Molecular dynamics
(MD) simulations provided the morphology of PG-1 aggre-
gates on the anionic bilayer. We further used thioflavin-T
(ThT) staining to investigate whether the PG-1 peptides
form a fibril in solution, and performed MD simulations to
confirm the stability of preassembled PG-1 fibrils in water.
To understand the morphological basis of the b-sheet fibrils
of PG-1, we compared its structures with the structures of
Ab1–42 fibrils on the same mica surface and lipid bilayers.
Our observations illustrate that antimicrobial peptides share
a common structural motif with amyloids when they are
exposed to similar environments. The similarity between
b-rich AMPs and amyloids leads us to propose a functional
relatedness between them.MATERIALS AND METHODS
Materials
PG-1 peptides were synthesized in Dr. Carl Saxinger’s laboratory at the
National Cancer Institute (National Cancer Institute-Frederick, MD) (24).
For storage, the peptides were dissolved in 0.01% acetic acid to 1 mg/mL
concentration and aliquoted. Aliquots were stored at 20C and thawed
only once before use. Ab1–42 peptides were purchased from AnaSpec
(Fremont, CA). These were dissolved in 1% NH4OH (Sigma-Aldrich,
St. Louis, MO) solutions, aliquoted to concentrations of 1mg/mL and stored
at 20C for ~30 days before use. Molecular Biology Grade water used for
solution preparation andDulbecco’s phosphate buffered salinewithout Ca2þ
and Mg2þ used for AFM imaging were from Fisher Scientific (Pittsburgh,
PA). Phospholipids, DOPS and POPE were purchased from Avanti polar
lipids (Alabaster, AL).AFM imaging
AFM images were acquired using a 5.30 Nanoscope controller (Veeco,
Santa Barbara, CA) with an Extender electronics module. Imaging in liquid
was performed in phosphate-buffered saline (PBS) at room temperature
using a fluid cell (Veeco). Before use, the fluid cell was cleaned in detergentBiophysical Journal 100(7) 1775–1783for ~20 min and rinsed vigorously in a continuous flow of ultrapure water
(Millipore, Billerica, MA). Oxide-sharpened Si3N4 cantilevers (Veeco) with
nominal spring constants (kn) of 0.12 N/m were used. Images in liquid
were acquired in tapping mode at scan frequencies of 0.5–1.0 Hz and
drive amplitudes below 100 mV. The cantilever oscillation frequency was
5–10 kHz. In air, images were acquired in contact mode at forces of
1–5 nN. Image analysis was performed using the Veeco software. Some
of the AFM images were low-pass filtered to remove noise.Sample preparation
Freshly dissolved PG-1 peptides, with concentrations ranging from 200
to 300 mg/mL in PBS, were allowed to absorb on freshly cleaved mica
for ~20–30 min before imaging. For imaging Ab1–42 fibril formation in
fluid, the mica surface was first imaged in PBS and subsequently Ab1–42
peptides were added to the fluid cell to a final concentration of 300 mg/mL.
Both measurements were carried out at room temperature. For imaging
Ab1–42 fibrils in air, a 1 mg/mL aliquot of Ab1–42 peptides was incubated
for 72 h at 37C. A 10 mL droplet with fibrils was deposited on mica for
~2 min, after which it was rinsed with ultrapure water to remove salt resi-
dues and other weakly adsorbed materials.ThT staining
Fibrillogenesis was measured using ThT fluorescence measurements.
Briefly, ThT was added to 1 mg/mL of PG-1 at a final concentration of
20 mM. 100 mL of this mixture was deposited in 6 wells (replicates) in an
opaque black walled 96-well plate (Nunc) and incubated at room tempera-
ture for 6 h. Fluorescence was recorded (Ex/Em: 450/482 nm) on a spectro-
fluorometer (Spectra Max XS, Molecular Devices, Sunnyvale, CA). Ab1–42
at 100 mM concentrations was used as a positive control; ThT mixed with
PBS was used as a blank. Blank fluorescence was subtracted from all treat-
ments and plotted against time.MD simulations
The PG-1 fibrils were made with 10 identical PG-1 b-hairpins, initially
arranged to form a linear b-sheet. Depending on the b-hairpin arrangement,
the PG-1 fibril was assembled into two distinct b-sheet motifs; antiparallel
(turn-next-to-tail) and parallel (turn-next-to-turn) b-sheets in a multimeric
NCCN packing mode (see Fig. S1 in the Supporting Material) (45). We
used theprerelaxedb-hairpin structure obtained frompreliminary simulations
of the solution NMR structure of a PG-1 monomer (46) in the lipid environ-
ment, as described in previous simulation protocols (13,24). The 10-mer
PG-1 fibril was minimized with a rigid body motion for the peptides to
enhance the formationof intermolecular backbonehydrogenbonds (H-bonds)
within a b-sheet, and then deposited on the surface of DOPS/POPE bilayer
(mole ratio 1:2). Because the simulation method closely follows the protocol
previously described for PG-1 monomer (47), dimer (48), octamer channel
(13), and decamer channel (24), in this study we only describe briefly key
parameters used for the decameric PG-1 fibril simulations.
We constructed a unit cell containing a 10-mer PG-1 fibril, lipids, salts,
and waters; overall almost 160,000 atoms. For the lipid bilayer, 480 lipids
(160 DOPS and 320 POPE lipids) constitute the lateral cell. The lateral
dimension of the mixed lipid bilayer was chosen to be 119.1  119.1 A˚2.
We used the values of 65.3 A˚2 per DOPS (49) and 56.0 A˚2 per POPE
(50) at 303 K. TIP3P waters were added and relaxed through a series of
minimization and dynamics. The system contains MgCl2 and NaCl at the
same concentration of 50 mM to satisfy a total cation concentration of
~100 mM. In addition to the decameric PG-1 fibril simulations on the
lipid bilayer, we also performed the simulations for the decameric PG-1
fibrils in the water box. A series of minimization and dynamics for the
PG-1 fibril/water system were performed with the same simulations param-
eters used for the PG-1 fibril simulations.
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FIGURE 1 AFM height images of (A) PG-1 and
(B) Ab1–42 fibrils on mica. (C) Higher resolution
image of a PG-1 fibril displaying a helical intrafi-
brillar structure. Corresponding cross sections for
the (D) PG-1 and (E) Ab1–42 fibrils. (F) Cross
section for the helical intrafibrillar structure of
PG-1 fibril.
Antimicrobial PG-1 Forms Fibrils 1777The CHARMM program (51) was used to construct the set of starting
points and to relax the systems to a production-ready stage. In the preequi-
librium stages, the initial configurations were gradually relaxed, with the
peptides held rigid. A series of dynamic cycles were performed with the
harmonically restrained peptides in the fibrils, and then the harmonic
restraints were gradually diminished with the full Ewald electrostatics
calculation and constant temperature (Nose´-Hoover) thermostat/barostat
at 303 K. For production runs to 50 ns, the NAMD code (52) on a Biowulf
cluster at the National Institutes of Health, Bethesda, MD (http://biowulf.
nih.gov) was used for the starting point. Averages were taken after 10 ns
discarding the initial equilibrarion period.t = 214 min
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FIGURE 2 Dynamical changes in length and surface concentration of the
PG-1 fibrils on mica. (A–D) Time sequential images were taken at the times
indicated in the figure in a 1.75 mm  1.75 mm area. The different colored
arrows denote different types of fibril growth as explained in the text. Time
zero corresponds to the time when the 200 mg/mL solution of PG-1 peptides
came in contact with the mica surface.RESULTS
PG-1 fibril morphologies on mica
AFM images of PG-1 peptides adsorbed on mica surfaces
reveal several fibrillar structures (Fig. 1 A). The typical
height (h) of these structures ranges between 3 and 4 nm
and their typical width (w) is ~5–10 nm after tip-induced
broadening is corrected using the relationship w ¼ wm
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2Rhþ h2p ; wm is the measured width in AFM images
with an AFM tip of radius (R) (27,53,54). A value of R ¼
30 nm was assumed. On the basis of the lowest heights
measured in these experiments, the fibril appears to consist
of multilayered b-sheets. The planar geometry of these
fibrils correlates well with the geometry of fibrils reported
for amyloids and proteins with amyloid-like behavior
(27–29,53). Typical fibril lengths are in the range of
50–250 nm, but these values increased as fibrils grew during
imaging (see below). Most of the fibrillar structures are
linear without turns, although some of them have mild
curvatures. Their orientations follow different directions
on the surface and appear not to be directly correlated to
the hexagonal symmetry of mica. Several times new smaller
fibrils branched out in different directions from a single
point of a preexisting fibril (see white arrow in Fig. 2 A).
AFM images of amyloid Ab1–42 fibrils were acquired for
comparison. Fig. 1 B shows the fibrilar structure of Ab1–42peptides incubated at 37C for 72 h. The heights measured
for these fibrils were in the same range as the height of the
fibrillar structures observed for PG-1. The widths, w, of
these fibrils were ~10 nm, in agreement with previous
reports. Typical lengths were 100–200 nm. Numerous
fibrillar structures have been reported for amyloid peptides
and have been broadly classified as filaments, protofibrils,
type I fibrils, and type II fibrils. Although filaments and pro-
tofibrils have typical lengths <100 nm, lengths of fibrils
are >100 nm. Based on these lengths, fibrillar structures
in this article will be referred to as either filaments or fibrils
and no strict distinction between filaments and protofibrils
or type I and type 2 fibrils will be made.Biophysical Journal 100(7) 1775–1783
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1778 Jang et al.In addition to the amyloid-like fibrillar structures observed
for PG-1, a helical intrafibrillar structurewas observed in some
of these fibrils (Fig. 1 C), similar to those reported for the
fibrillar structures for Ab1–42 and Ab1–40, as well as for other
amyloids (27–29). The helical structure observed for the PG-1
fibrils in thiswork is right-handed, has a periodicity of~41 nm,
and has the corrugation amplitude of ~0.75 nm.100 200
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FIGURE 3 (A) Plot of fibrils length, L, as a function of time, t, for the
fibrils marked with arrows in Fig 2. Open squares in this plot correspond
to black arrows, solid circles to red arrows, open downward triangles to
blue arrows, open upward triangles to green arrows, and open circles to
orange arrows. (B) ThT fluorescence intensity, I, specific to amyloid fibrillo-
genesis shows that PG-1 andAb1–42 peptides form amyloid fibrils in solution
after 6 h incubation at room temperature. For Ab1–42, a 10 mMconcentration
was used, whereas for PG-1 a 200 mg/mL concentration was employed.
Higher fluorescence for PG-1 suggests more rapid fiber formation.Kinetics of PG-1 fibrils growth
In situ AFM images of PG-1 fibrils on mica show a dynamic
behavior with fibril length and surface concentration
increasing significantly over a few hours (Fig. 2). Although
the fibril density is ~20 fibrils/mm2 ~120 min after incuba-
tion (Fig. 2 A), it increases to ~60 fibrils/mm2 in 90 min
(Fig. 2 C). Fibrils that display different growth behavior
are shown by colored arrows at the different times. Yellow
arrows show a fibril that maintains approximately the
same length over time; black arrows show another fibril
that maintains a length of ~125 nm for ~130 min and then
increases its length at a rate of ~4.3 nm/min. The red arrows
(Fig. 2, B and C) show two fibrils stacked on top of one
another. In this case, the fibril adsorbed directly on the
mica surface (red arrow) grows at a rate of ~12.2 nm/min
and the fibril on top (orange arrow) grows at only 2.1 nm/
min. Fibril growth on the surface of another fibril involves
adsorption of oligomers on the surface of the lower fibril
and this type of interaction appears to be less favorable
than the fibril/mica interaction. Consequently, fibril on fibril
adsorption is not observed as frequently as fibril on mica
adsorption in the AFM images.
The lengths of fibrils were plotted as a function of time to
investigate their growth kinetics (Fig. 3 A). Because all
curves display plateaus of different time lengths, their
growth mechanism appears compatible with sudden growth
followed by long pauses, also observed by others (55).
Typical growth rates of the fibrils are in the range of
4–4.5 nm/min, although an average value of 6.5 5
3.8 nm/min is obtained due to the influence of some fibrils
with very fast growth rates (see for instance the fibril
marked with red arrows in Fig. 2 B). Fluorescence of ThT
(Fig. 3 B), a dye known to fluoresce upon binding to amyloid
fibrils, suggests that both PG-1 and Ab1–42 fibrils are
produced in solution and not induced by the mica surface.
When the kinetics of PG-1 fibril growth is compared with
Ab1–42 fibril formation in unseeded conditions at room
temperature, a fairly different behavior is observed (Fig. 4).
Even after ~4 h adsorption on mica, only thin Ab1–42 fila-
ments/protofibrils with heights of ~2 nm, widths <5 nm,
and lengths<100 nm could be observed (Fig. 4 D). At times
when PG-1 fibrils are already formed on the mica surface
(Fig. 2), only unstable, weakly adsorbed Ab1–42 filaments/
protofibrils and globular structures are seen (Fig. 4, A and
B). After a period of 3–3.5 h (Fig. 4 C), a continuous film,
consisting of globular oligomers and thin filamentous struc-Biophysical Journal 100(7) 1775–1783tures, is observed. Furthermore, the rapid kinetics of PG-1
fibril formation was also examined using staining by ThT
(Fig. 3 B). In agreement with AFM data, the higher fluores-
cence intensity measured for PG-1 suggests faster kinetics
of PG-1 fibril formation than for Ab1–42 under conditions
used in this work. It should be noted, however, that
morphology and kinetics of Ab amyloid fibril formation
can be highly dependent on preparation conditions such as
temperature and seeding; consequently, growth rates as
high as 300 nm/min have been measured for Ab1–40 fibrils
seeded for one week and then incubated at 37C (56).Absence of PG-1 fibrils on the lipid bilayer
We examined if a biologically relevant surface, e.g., a lipid
bilayer would also support PG-1 fibril conformations. For
PG-1 peptides added to preformed DOPS/POPE 1:1 (w/w)
lipid bilayer, AFM images sometimes showed PG-1 oligo-
mers adsorbed on the bilayer, but no fibril formation
250 nm
1500 nm 1500 nm
1500 nm
t = 44 min t = 123 min
t = 213 min t = 244 min
A B
C D
FIGURE 4 Time sequence of adsorption for a 300 mg/mL solution of
Ab1–42 peptides on mica. Amorphous and weakly adsorbed structures
were observed for ~2 h (A and B). Only after longer times (~3 h), globular
structures and small and thin filaments could be clearly seen (C and D). It
should be noticed that images were not acquired in the same spot, but rather
in neighboring areas of the same sample.
Antimicrobial PG-1 Forms Fibrils 1779(Fig. 5). On the basis of the oligomer height (> 2 nm), we
speculate that these oligomers can adopt a multilayered
b-sheet structure or interact with the bilayer in different
orientations. Considering the heights of some of the parti-
cles (up to 20–25 nm), lipid extraction from the membrane
and subsequent accumulation around PG-1 oligomers is also
possible (57). The final concentration of PG-1 added to the
lipid bilayer was ~100–150 mg/mL, and even prolonged
scanning did not show formation of any fibrils.
We usedMD simulations to examine PG-1 fibril formation
on the anionic lipid bilayer. Initially, preformed decameric
PG-1 fibrils with antiparallel and parallel b-sheet arrange-
ments were deposited on the surface of DOPS/POPE bilayer
(mole ratio 1:2). During the simulations, as expected, the3000 nm 3000 nm
0
50
nm
A B
FIGURE 5 AFM images of DOPS/POPE bilayer (A) before and (B) after
addition of PG-1 peptide solution. Data were obtained in different regions
of the same bilayer and are offline zooms of original 4 mm  4 mm images.
Dark colors denote lower heights in color-coded height scale.PG-1 fibrils are unstable and break apart into small parts
(Fig. 6). For the antiparallel b-sheet, the PG-1 fibril breaks
into three parts; trimer, pentamer, and dimer (Fig. 6 A). Simi-
larly, the parallel b-sheet fibril also breaks into three parts;
two dimers and hexamer (Fig. 6 D). Discontinuities of the
b-sheet network due to breakages of the intermolecular back-
bone H-bonds in the PG-1 fibrils occur early in the simula-
tions and remain unchanged thereafter (Fig. 6, B and E). In
contrast, the intramolecular backbone H-bonds keep intact
due to strong disulfide bonds in the b-hairpin (Fig. 6, C and
F). Thus, no PG-1 fibril formation on the surface of anionic
bilayer is observed, but small PG-1 oligomers might be
highly populated. This behavior is in good agreement with
the AFM images (Fig. 5).
From the MD simulations we observe that these broken
pieces, now low molecular mass PG-1 oligomers with
further optimized b-sheet, tend to insert into the bilayer.
The three-dimensional densities for the positions of the lipid
headgroups clearly indicate the roughness of the bilayer
surface when embedded with the peptides (Fig. 7). The
headgroup density map denotes the average shape of the
anionic bilayer surface during the simulation. The rough-
ness of the bilayer surface is clearly related to membrane
thinning or disruption. It has been demonstrated that PG-1
monomer (47) and dimer (48) mediate localized membrane
thinning, possessing the ability to diffuse into the membrane
core, and ultimately clustering to form ion channels
(10,13,24). As a whole, the simulations show that the larger
10-mer b-sheet PG-1 fibril is not able to insert into the
bilayer, but small PG-1 oligomers can insert into the bilayer.
This behavior suggests an explanation for why PG-1 fibrils
divide into small pieces leading to channel formation, and
why we were unable to observe experimentally fibril forma-
tion when PG-1 is in contact with an anionic lipid bilayer.
We also simulated the PG-1 fibrils in water. During the
simulations, both antiparallel and parallel b-sheet fibrils of
PG-1 divided into two separated b-sheets (Fig. S2).
However, the morphology of the hexameric and tetrameric
b-sheets in water is totally different from those observed
in the lipid simulations. While the b-sheets on the bilayer
adopt a planar shape, the b-sheets in water are twisted,
showing a cross b-structure (or helical structure as
mentioned above) commonly observed in amyloid fibrils
(58,59). The cross b-sheets may serve as seeds for fibril
growth when PG-1 concentration in solution increases. We
conclude that PG-1 can produce fibrils in solution, consis-
tent with the ThT staining.DISCUSSION
We used complementary techniques of AFM, MD simula-
tion, and ThT staining to investigate the amyloidogenic
properties of PG-1. Our AFM results show that PG-1
peptides form fibrils on the highly hydrophilic mica surface.
The PG-1 fibrils have similar morphologies and dimensionsBiophysical Journal 100(7) 1775–1783
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FIGURE 6 (A) Fibril structure averaged over the simulation in a ribbon representation, (B) fractions of intermolecular backbone H-bonds, Qinter, as a func-
tion of time, t, for the neighboring pairs of peptides, and (C) average fractions of intramolecular (solid circles) and intermolecular (open circles) backbone
H-bonds, Q, as a function of peptide number for the antiparallel b-sheet fibril of PG-1 on the surface of DOPS/POPE: (1:2) bilayer. (D–F) the same for the
parallel b-sheet fibrils of PG-1. In the peptides, hydrophobic residues are shown in white, polar and Gly residues are shown in green, and positively charged
residues are shown in blue. Both antiparallel and parallel b-sheet fibrils break into 3 parts; trimer, pentamer, and dimer in the antiparallel, and two dimers and
hexamer in the parallel b-sheet fibrils as denoted by different colors of transparent surface for the parts in A and D.
1780 Jang et al.to the well-studied fibrils produced by the amyloidogenic
Ab1–42. In addition, PG-1 fibrils exhibit a helical intrafibril-
lar structure, which is a typical fibril structure formed
by Ab1–42, Ab1–40, and other amyloidogenic peptides
(27–29), although different periodicity and handedness are
occasionally observed in the PG-1 fibrils. These helical
structures have been attributed to two protofibrils wrapped
around each other, thus forming a helical (28,29) or cross
b-structure (58,59).
PG-1 forms amyloid-like fibrils with relatively fast
kinetics. Several experimental studies suggested that two
or more days of incubation are necessary for Ab1-42 or
Ab1-40 peptides to form fibrils (27,28,30,36). In our AFM
experiments, Ab1–42 fibrils can be observed after 72 h incu-Biophysical Journal 100(7) 1775–1783bation at 37C. The dimensions of the thin filamentous
structures of Ab1–42 observed in solution upon 3 h of adsorp-
tion are significantly smaller than the PG-1 fibrils, indi-
cating that the growth of Ab1–42 fibrils is relatively slow.
On the other hand, considerably faster kinetics of fibril
formation is observed for PG-1, even after taking into
account the different molar concentrations used in the
experiments (100 mM for PG-1 and 45 mM for Ab1–42).
Both AFM imaging and MD simulation results show that
PG-1 fibril is not produced on the anionic bilayer. Instead,
small PG-1 oligomers are observed on the surface of the
lipid bilayer, implying PG-1 diffusion into the membrane
core. This is in contrast to the results of PG-1 fibrils on
the solid mica surface that does not allow PG-1 penetration.
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FIGURE 7 Three-dimensional density maps of the lipid headgroup for
the anionic DOPS/POPE: (1:2) bilayer. The upper panels are the normal
views of the upper bilayer surfaces embedding the (A) antiparallel and
(B) parallel b-sheet fibrils of PG-1. The lower panels are the reciprocal
normal views of the lower bilayer surfaces without the peptides.
Antimicrobial PG-1 Forms Fibrils 1781Absence of PG-1 fibrils on the fluidic lipid bilayer suggests
that PG-1 is evolutionarily optimized for microbial bilayer
penetration. This is further supported by works showing
that PG-1 binds to LPS and lipid A (the phospholipid core
of LPS) moieties, typical components of bacterial cells
(4,5). Our simulation results show that preassembled
b-sheets of PG-1 fibrils break into several small oligomers,
because such large molecules as a whole are not able to
dislocate into the membrane core. However, upon size
reduction, these small oligomers can significantly induce
membrane thinning effects such as those observed in the
monomer and dimer PG-1 simulations (47,48). These obser-
vations provide important information for PG-1 activity
involving cell membrane damage and their ability to form
ion channels with loosely attached subunits when they pene-
trate the cell membrane (13,24). Furthermore, the PG-1
channel morphology with a b-sheet subunit motif is in
agreement with Alzheimer’s Ab ion channels (13,32–43),
indicating that PG-1 and Ab share a common cellular mech-
anism, such as membrane disruption and large pore forma-
tion, preceded by toxic ion channel formation, finally
leading to cell death.
Further investigation using ThT staining suggests that
PG-1 forms fibrils in solution. High levels of fluorescence
in solutions incubated with PG-1 peptides under conditions
similar to those used in the AFM experiments clearly indi-
cate the PG-1 fibril formations. MD simulation results
show that PG-1 b-sheets in water contain a common cross
(or helical) b-structure in amyloid fibrils (58,59). Although
preassembled planar PG-1 b-sheets in water are divided into
two parts, these PG-1 oligomers exhibit more amyloid fibril
characteristics than those observed on the lipid bilayer. We
speculate that as seeds the small cross b-sheets of PG-1 arecapable of developing to protofibrils or mature fibrils in
water when PG-1 concentration is increased (45).
PG-1 fibrils on the mica surface are stable and able to
grow. We hypothesize that fibril formation on mica occurs
by fibrils preformed in solution, which subsequently adsorb
on the mica surface and serve as seeds for the fibril growth
observed in Fig. 2. Fibrils on mica are likely to be stabilized
by favorable electrostatic interactions between the posi-
tively charged amino acid residues and the negatively
charged mica surface. When fibrils are adsorbed on mica,
their configuration in solution may be altered as a result
of these interactions. On anionic lipid bilayers, fibril disin-
tegration and bilayer disruption occur faster and these
processes predominate over fibril growth.
To conclude, both PG-1 and Ab form fibrils in solution at
room temperature and these fibrils can be adsorbed on the
mica surface. In these cases, PG-1 fibrils grow relatively
faster than unseeded Ab fibrils. Thus, our study shows that
PG-1 possesses amyloidogenic properties. Furthermore,
under proper environments, PG-1 retains its fibril state
with morphologies similar to those of amyloids, which are
structural hallmarks of amyloid diseases. Moreover, PG-1
abandons the fibril architecture on the lipid bilayer, and forms
small oligomers. The presence of small oligomers suggests
the peptide’s cytolytic mechanism in the cellular membrane.
Small PG-1 oligomers diffusemore easily into themembrane
core, which is again consistent with the mechanism of
amyloid diffusion. These combined results support the
conjectures that amyloids are cytotoxicwith an antimicrobial
activity and that cytotoxic AMPs form fibrils, hence are
amyloidogenic. They suggest a possible functional role of
amyloids as antibiotics. Interestingly, both are capable of
forming channels in the membrane inducing cell toxicity,
and in both cases, the channels consist of b-structures, with
structural, functional, and biological similarities, suggesting
a shared mechanism of action (60–62). Over the last few
years, the question of the function of amyloids has been the
focus of immense interest in the community (63–67).
Although currently there is no direct evidence, the observa-
tions that we make here, that PG-1 is like an amyloid and
an amyloid behaves like antibacterial peptides such as
PG-1, raise the possibility that the Ab channel may also func-
tion in a way similar to that of a cytolytic peptide.SUPPORTING MATERIAL
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